06-reference

not boring wdoo 218

2026-11-06·reference·source: Not Boring·by Packy McCormick
autonomous-deliveryspace-manufacturingbiotechnot-boringweekly-dose-of-optimism

Why this is in the vault

Filed for item (2), Zipline's $1.5B raise and nationwide Walmart drone-delivery contract — direct longitudinal continuity with the vault's 2024 Zipline founder-interview note, now showing the autonomy-at-scale trajectory two years on; also logging that Runway reclaimed the full sponsor slot this issue, breaking Reducto's three-consecutive-issue streak (#215, #216, #217).

Mapping against Ray Data Co

The load-bearing connection is item (2), Zipline, read against [[2024-08-29-moonshots-ep117-keller-cliffton-zipline-drones]] — the Aug 2024 Diamandis interview with CEO Keller Rinaudo Cliffton already in the vault. Then: 80M+ autonomous miles, 1.1M deliveries across 8 countries, $4B+ valuation. Now: $1.5B raised at a $21.5B valuation (~5.4x in roughly two years), 150M+ commercial autonomous miles with zero safety incidents, flight volumes up 18x in 18 months, over a million deliveries per metro per year, and what Zipline calls "the largest autonomous vehicle contract in human history" — a Walmart deal scaling to 300 supercenters nationwide. That's a clean, citable before/after on how a real physical-world autonomous system actually compounds from near-impossible proof-of-concept to national infrastructure, not just a press-release number — relevant to the founder's "bigger problem + network" ambition thread (project_ambition_bigger_problem_network) now that he's pointed at programmable-engineering/hardware exposure (home lab, workshop, SendCutSend) rather than HCLS.

Secondary: item (4), DARPA's NOM4D automated in-space assembly demo. The program manager's framing — a simple gantry robot joining truss pieces, deliberately "without fancy robotics or advanced algorithms," compared to Tinkertoys or K'nex — is a small but real data point for the same ambition thread: start with legible, simple mechanisms rather than over-engineered ones. The item also carries a disclosed one-liner ("not boring capital portfolio company Varda is currently making drugs in space") — a portfolio mention, not a promotional item, noted for completeness.

Everything else in the issue (INOVIO's plasmid immunotherapy, DREADDs in epilepsy, the Telepathy Tapes reincarnation series) is pure biotech/neuro/personal-curiosity content with no real RDCO hook — HCLS was explicitly dropped as the founder's space on 2026-10-05, so these are logged below but not mapped.

⚠️ Sponsorship

Sponsor: Runway — full "This Week's Dose is brought to you by" block at the top, not just a video-production credit line. This is the same already-confirmed quarterly Runway partnership logged in [[2026-10-13-not-boring-runway-world-models]], here taking the full weekly sponsor slot rather than an in-item credit. Packy nests his own self-promo inside the paid block — "you can read my essay with co-founder Anastasis Germanidis" — consistent with the known pattern of layering his own content into the Runway relationship rather than running it as pure third-party advertising.

Streak break: Reducto had sponsored #215, #216, and #217 consecutively. Runway's return as the full sponsor this issue breaks that at three. No posture change warranted — the #216/#217 notes already set "default sponsor, verify per issue" rather than assuming Reducto would run indefinitely; this is that check working as intended, not a surprise.

Curation section

  1. FDA approves Voceryq (INOVIO) — first plasmid DNA-based immunotherapy approved in the US, treating recurrent respiratory papillomatosis (HPV-6/11 wart-like airway growths requiring repeat surgery). 7 of 26 trial patients were surgery-free for a full year after treatment; the platform is designed to swap in payloads for other HPV diseases, cancers, and infections. Biotech outside the current RDCO relevance threshold — logged, not mapped.
  2. Zipline raises $1.5B — see Mapping above; load-bearing item.
  3. DREADDs work in humans — first adult human study placed inhibitory DREADDs in the hippocampus of 3 epilepsy patients, cutting seizures ~93% with only mild side effects; a genuinely new, bidirectional control "knob" over specific brain circuits. No RDCO mapping — personal-curiosity-adjacent at most, not pursued.
  4. NOM4D automated in-space assembly (DARPA/Caltech) — see Mapping above; secondary item.
  5. Telepathy Tapes Season 3: The Reincarnation Records — Packy's long-running personal rabbit hole (cites UVA's Division of Perceptual Studies and its 2,500+ documented cases of children reporting past-life memories). Pure personal/spiritual curiosity content; zero business mapping, not pursued.

Zero deep-fetches this issue. The one item that clears the relevance bar (Zipline) is fully substantiated by the newsletter's own numbers plus the vault's existing 2024 profile — nothing left to chase. NOM4D's detail is likewise complete in the blurb. Everything else fails the relevance threshold outright.

Related